Overview for Our Investors

Galaxy CCRO is developing biomarker-based diagnostic technologies designed to support time-critical clinical evaluation. The company’s programs combine scientific research, clinical validation, and strategic partnerships to advance innovative healthcare solutions. Investors can explore the company’s strategy, development milestones, and future opportunities in this section.